February 26, 2019
The 2019 Sternfels Prize for Drug Safety Discoveries Announces Winner. Click here for the official press release.
September 5, 2018
The 2019 Sternfels Prize for Drug Safety Discoveries Contest Opens. Click here for the official press release.
July 20, 2018
Recently published in Nature Genetics, researchers have identified a gene variant as a risk factor for developing a treatment-related liver injury. ELS plans to partner with lead author to replicate their findings.
June 15, 2018
Emerald Lake Safety Presenting Multiple Posters at September 23-25 ACCP Meetings in Maryland. Click here for the official press release.
The FDA will update generic chemotherapy drug labels that no longer have brand name reference products to ensure that the labels reflect how they are being used today. The push, known as Project Renewal, will make sure “you know the right doses and pediatric uses” along with any new indications.
Check out this great success story highlighting the other side of drug safety: ensuring proper patient medication use at home. You’ll never guess what the secret was to finding the cure…
A decade-long study finds that a third of the drugs approved by the FDA had postmarket safety events. Read how the FDA required manufacturers to add new warnings, provide safety information, and even withdraw some of the drugs from the market.
Watch as reporters test pharmacies by bringing them prescriptions for dangerous drug combinations. Spoiler: Half of the pharmacies issue prescriptions without even a warning.
Ever think to yourself that the information on your medication label is too scary, overwhelming, or confusing? The Academy of Medical Sciences says this needs to change.
Learn how a team in Europe found out that the efficacy of certain drugs are different in men and women. Some researchers are even calling for companies to manufacture gender-specific versions of their drugs.
Nearly half of people between the ages of 70 and 79 take at least five pills a day, while for some that number exceeds 20 medications. This report describes the polypharmacy problem, highlights a growing “deprescribing” movement, and offers advice to individuals.
Why is a drug prescribed for a condition that affects less than 1% of all Americans selling for nearly $300 million a year? You will never believe the tangled web of deceit from the company, doctors, pharmacists, and even nurses.